(S)-tert-Butyl 4-(4-(4-(2-amino-3-methoxy-3-oxopropyl)phenoxy)butyl)piperidine-1-carboxylate, 97%, 1g

2-Methylvaleric Acid>98.0%(GC)(T)25mL

1-Bromo-2,4-difluoro-5-nitrobenzene>98.0%(GC)1g

(2E)-3-(4-bromophenyl)-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

Mandatory signs in accordance with ISO 7010, Safety gloves mandatory, 50 mm, 1 piece

tert-Butyl 4-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 1g

Sodium 2-Acrylamido-2-methylpropane-1-sulfonate (ca. 50% in Water) (stabilized with MEHQ)500g

N-Butyl-2-chloro-acetamide, 95.0%, 25g

(3S)-3-(2,2,2-Trifluoroethyl)pyrrolidine;hydrochloride, 98%, 500mg

Ethyl 2-(2-(methylthio)-6-oxo-1,6-dihydropyrimidin-5-yl)acetate, 95.0%, 5g

Methyl piperazine-1-carboxylate hydrochloride, 95.0%, 250mg

(2E)-3-(4-bromophenyl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

(2S)-2-(4-(3-Amino-1,9-dioxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzamido)pentanedioic acid, 95%, 10mg